Phenylalanine
Drug profile
Also known as: L-Phenylalanine
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Phenylalanine is a drug catalogued in DrugCentral. DrugCentral lists 8 molecular targets, including PKM, Cacna2d1 and GPR139.
- Molecular targets: PKM, Cacna2d1, GPR139 and Slc7a5 (8 listed in DrugCentral).
- Molecular formula: C9H11NO2; molecular weight 165.19 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Contraindications (11)
- Classical phenylketonuria
- End stage renal disease
- Heart disease
- Humoral hypercalcemia of malignancy
- Hypercalcemia
- Hypercalciuria
- Kidney disease
- Kidney stone
- Poisoning by digitalis glycoside
- Sarcoidosis
- Ventricular fibrillation
Mechanism & targets
Molecular targets (8)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Pyruvate kinase PKM | PKM | unknown | IC50 10.26 |
| Voltage-dependent calcium channel subunit alpha-2/delta-1 | Cacna2d1 | unknown | Ki 6.01 |
| Probable G-protein coupled receptor 139 | GPR139 | agonist | IC50 4.51 |
| L-type amino acid transporter 1 | Slc7a5 | unknown | Ki 4.26 |
| Large neutral amino acids transporter small subunit 1 | SLC7A5 | unknown | IC50 4.16 |
| E3 ubiquitin-protein ligase XIAP | XIAP | unknown | IC50 4.10 |
| Intestinal alkaline phosphatase | ALPI | unknown | IC50 4.10 |
| Intestinal-type alkaline phosphatase | ALPI | unknown | IC50 4.00 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| — | FDA | — | — |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Foetal growth restriction | 67.1 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Phenylalanine is on its molecule page.
| Molecular formula | C9H11NO2 |
|---|---|
| Molecular weight | 165.19 g/mol |
| CAS number | 63-91-2 |
| InChIKey | COLNVLDHVKWLRT-QMMMGPOBSA-N |
| PubChem CID | 6140 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Phenylalanine work?
Its molecular targets in DrugCentral include PKM, Cacna2d1, GPR139 (agonist) and Slc7a5.
What is the chemical formula of Phenylalanine?
Phenylalanine has the molecular formula C9H11NO2 and a molecular weight of 165.19 g/mol.
Browse: all drugs starting with P · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2144 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL301523 — compound record and bioactivity
- PubChem CID 6140 — chemical identifiers
- DrugBank DB00120 — drug record
- FDA UNII 47E5O17Y3R — substance identity
- DailyMed: FDA labels for Phenylalanine — current prescribing information (label search)
- UniProt P14618 (PKM) — target protein
- UniProt Q6DWJ6 (GPR139) — target protein
- UniProt Q01650 (SLC7A5) — target protein
- UniProt P98170 (XIAP) — target protein
- UniProt P09923 (ALPI) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.